Remi M. Adelaiye-Ogala PhD

Remi Adelaiye-Ogala

Remi M. Adelaiye-Ogala
PhD

Assistant Professor

Department of Medicine

Jacobs School of Medicine & Biomedical Sciences


Specialty/Research Focus

Epigenetics; Genomics and proteomics; Oncology; Preclinical Research; Transcriptomics; Translational Research

Contact Information
Clinical and Translational Research Center
875 Ellicott Street, Room 6081
Buffalo, New York 14203
Phone: 7168872202
remiadel@buffalo.edu



Education and Training:

  • Fellowship, Postdoctoral Fellow, Center for Cancer Research, National Cancer Institute, NIH (2020)
  • Graduate Research Assistant, School of Medicine, Indiana University (2017)
  • PhD, Cancer Pathology, University at Buffalo, Roswell Park Cancer Institute Division (2017)
  • BS, College of Liberal Arts & Sciences, State University of New York at Fredonia (2009)

Employment:

  • Assistant Professor, Department of Medicine, Division of Hematology/Oncology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo (2022-present)
  • Graduate Faculty Member, Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo (2022-present)
  • Adjunct Research Assistant Professor, Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo (2021-present)
  • Research Assistant Professor, Department of Medicine, Division of Hematology/Oncology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo (2021–2022)
  • Research Technician, Health Research Inc. Roswell Park Cancer Institute (2010–2012)

Awards and Honors:

  • Clinical and Translational Science Institute Pilot Award (2022)
  • Invited panel speaker, Prostate Cancer Foundation Women in Science Forum: Celebration of Achievements of Women in Prostate Cancer Oncology and Research, Prostate Cancer Foundation (PCF) 22nd Annual Retreat (2021)
  • Troup Award (2021)
  • Clinical Translational Science Institution (CSTI) K Scholar (2021)
  • Prostate Cancer Foundation Young Investigator Award (2019)
  • Congressionally Directed Medical Research Programs, PCRP Early Investigator Research Award (2019)
  • Scholar-in-Training Travel Award (2016)
  • Cancer research day Indiana University, 2nd prize-Poster presentation award (2015)
  • 1st prize-Award for outstanding postdoctoral fellow and graduate student poster presentation (2014)

Research Expertise:

  • Development and characterization of patient derived xenografts models for preclinical investigation.
  • Evaluating the efficacy of novel pipeline agents/compounds in 3D organoid cultures and animal models.
  • Functional transcriptomics and epigenetic in prostate and kidney cancers

Research Centers:

  • Center for Computational Research (CCR)
  • Center of Excellence in Bioinformatics and Life Sciences
  • Clinical and Translational Research Center (CTRC)

Grants and Sponsored Research:

  • June 2021–June 2023
    Targeting drivers of non-canonical AR cistrome associated with therapeutic resistance in advanced prostate cancer
    Kaleida Health Foundation
    Role: Principal Investigator
  • October 2019–October 2022
    Investigating Alterations in AR regulome following response to Kinase Inhibitors
    Prostate Cancer Foundation
    Role: Principal Investigator
  • September 2019–October 2021
    Dynamics of Epigenetic Mechanisms in the Akt Signaling Pathway and Its Influences on Drug Response in Advanced Prostate Cancer
    DOD-CDMRP-PCRP
    Role: Principal Investigator
  • March 2022
    Hijacking Therapeutic Resistance in High-risk Localized and Advanced Prostate Cancer
    University at Buffalo Clinical and Translational Science Institute (CTSI) via the NIH CTSA UL1
    Role: Principal Investigator

Journal Articles:

See all (10 more)

Professional Memberships:

  • Prostate Cancer Foundation (PCF) (2019–present)
  • Cancer Epigenetic Society (CES) (2017–present)
  • American Association for the Advancement of Science (2014–2019)
  • American Society for Clinical Oncology (ASCO) (2012–present)
  • American Association for Cancer Research (AACR) (2011–present)

Presentations:

  • "Effective Communication to Diverse Audiences" CTSI Scientific Communications Workshop Series, UB Clinical and Translational Science Institute- Workforce Development core (2022)
  • "Alterations in AR regulome associated with systemic therapies for advanced prostate cancers" Cancer Research Consortium Seminar Series, University at Buffalo-Cancer Research Consortium (2021)
  • "Epigenetic alterations associated with resistance to therapy: Focus in advanced renal cell carcinoma" Seminar, Department of Medicine, Imperial College, (2018)

School News:

In the Media:


Clinical Specialties:

Clinical Offices:

Insurance Accepted:



Contact Information

Clinical and Translational Research Center
875 Ellicott Street, Room 6081
Buffalo, New York 14203
Phone: 7168872202
remiadel@buffalo.edu